Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,288Revenue $M4.1Net Margin (%)-3,372.4Z-Score67.8
Enterprise Value $M2,078EPS $-0.7Operating Margin %-3,390.6F-Score2
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-3,372.4Higher ROA y-yN
Price/Book10.510-y EBITDA Growth Rate %2.6Quick Ratio12.8Cash flow > EarningsY
Price/Sales2,7165-y EBITDA Growth Rate %33.2Current Ratio12.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-43.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-46.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M84.3ROI % (ttm)-45.4Gross Margin Increase y-yN

Gurus Latest Trades with EXAS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXASPRIMECAP Management 2014-06-30 Buy 0.05%$11.17 - $17.27
($13.72)
$ 27.1698%New holding, 2491300 sh.2,491,300
EXASGeorge Soros 2014-06-30 Sold Out -0.03%$11.17 - $17.27
($13.72)
$ 27.1698%Sold Out0
EXASGeorge Soros 2014-03-31 Buy 0.03%$11.75 - $14.82
($13.45)
$ 27.16102%New holding, 200000 sh.200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXAS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
EXAS PRIMECAP Management 2014-09-302,496,3002.960.05+0.2%
Premium Most recent portfolio changes are included for Premium Members only!


EXAS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Conroy Kevin TPresident and CEO 2015-01-02Sell9,484$26.721.65view
ARORA MANEESHCOO 2015-01-02Sell2,495$26.721.65view
LIDGARD GRAHAM PETERChief Science Officer 2015-01-02Sell3,363$26.721.65view
LIDGARD GRAHAM PETERChief Science Officer 2014-10-29Sell8,015$24.6810.05view
CRAWFORD SALLYDirector 2014-10-20Sell83,304$23.4915.62view
Conroy Kevin TPresident and CEO 2014-10-20Sell400,000$23.4915.62view
ARORA MANEESHCOO 2014-10-20Sell247,500$23.4915.62view
LIDGARD GRAHAM PETERChief Science Officer 2014-10-20Sell150,000$23.4915.62view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2014-07-25Sell11,081$15.9969.86view
ARORA MANEESHCOO 2014-07-25Sell9,291$15.9969.86view

Press Releases about EXAS :

    Quarterly/Annual Reports about EXAS:

    News about EXAS:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Exact Sciences Corp Zayo Group Holdings Inc, Western Alliance Bancorp, a Oct 27 2014 
    CEO Kevin T. Conroy of Exact Sciences to Be Interviewed Live on Clear Channel -- iHeart Business Tal Oct 15 2014 
    Meridian Funds Comments on Exact Sciences Corp Jun 20 2014 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    Weekly CEO Buys Highlight: BFS, FL, BGC, AMCF, and EXAS Nov 28 2010 
    EXACT Sciences Corp. (EXAS) CEO Kevin T Conroy buys 6,000 Shares Nov 23 2010 
    EXACT Sciences Corp. (EXAS) CFO Maneesh Arora buys 2,500 Shares Aug 20 2010 
    cooldecency99 note on EXAS May 01 2010 

    More From Other Websites
    Exact Sciences Offers Update on Cologuard’s® Early Launch Trajectory Jan 12 2015
    Fifteen stocks for 2015, part 1 Jan 09 2015
    Exact Sciences Names Scott Coward as General Counsel Jan 09 2015
    Bulls returning to Exact Sciences Jan 07 2015
    Exact Sciences to participate in J.P. Morgan Healthcare Conference Jan 06 2015
    UPDATE: Lake Street Initiates Coverage On EXACT Sciences Jan 05 2015
    Exact Sciences: Additional Update on CMS Reimbursement for Cologuard® Jan 02 2015
    Learn the Exceptions to the In-Exact Science of Trading Dec 30 2014
    Update on CMS Reimbursement for Cologuard® Dec 19 2014
    Exact Sciences Addresses CMS Reimbursement for Cologuard® Dec 19 2014
    EXACT SCIENCES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 18 2014
    Exact Sciences Announces Pricing of Public Offering of Common Stock Dec 16 2014
    Exact Sciences Announces Agreement to Sell 4,000,000 Common Shares Dec 15 2014
    Exact Sciences Announces Mercy Hospital St. Louis Now Offering Cologuard® Dec 02 2014
    Equity markets end lower, though commodity prices staged a huge “squeeze” higher... Dec 01 2014
    Exact Sciences Announces Final Payment Decision for Cologuard® from the Centers for Medicare &... Nov 25 2014
    Cologuard® Wins Popular Science Magazine’s 2014 “Best of What's New” Award Nov 12 2014
    EXACT SCIENCES CORP Financials Nov 06 2014
    American Cancer Society Includes Exact Sciences' Cologuard in Colorectal Cancer Prevention and Early... Nov 06 2014
    American Cancer Society Includes Exact Sciences’ Cologuard in Colorectal Cancer Prevention and... Nov 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK